Tiziana Life Sciences (TLSA) Competitors $1.75 +0.17 (+10.76%) Closing price 04:00 PM EasternExtended Trading$1.72 -0.03 (-1.71%) As of 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TLSA vs. VIR, XERS, ABUS, ANAB, DAWN, GHRS, KALV, XNCR, EOLS, and STOKShould you be buying Tiziana Life Sciences stock or one of its competitors? The main competitors of Tiziana Life Sciences include Vir Biotechnology (VIR), Xeris Biopharma (XERS), Arbutus Biopharma (ABUS), AnaptysBio (ANAB), Day One Biopharmaceuticals (DAWN), GH Research (GHRS), KalVista Pharmaceuticals (KALV), Xencor (XNCR), Evolus (EOLS), and Stoke Therapeutics (STOK). These companies are all part of the "pharmaceutical products" industry. Tiziana Life Sciences vs. Its Competitors Vir Biotechnology Xeris Biopharma Arbutus Biopharma AnaptysBio Day One Biopharmaceuticals GH Research KalVista Pharmaceuticals Xencor Evolus Stoke Therapeutics Tiziana Life Sciences (NASDAQ:TLSA) and Vir Biotechnology (NASDAQ:VIR) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, risk, analyst recommendations, media sentiment, earnings and profitability. Does the media favor TLSA or VIR? In the previous week, Vir Biotechnology had 1 more articles in the media than Tiziana Life Sciences. MarketBeat recorded 2 mentions for Vir Biotechnology and 1 mentions for Tiziana Life Sciences. Tiziana Life Sciences' average media sentiment score of 0.00 equaled Vir Biotechnology'saverage media sentiment score. Company Overall Sentiment Tiziana Life Sciences Neutral Vir Biotechnology Neutral Do analysts rate TLSA or VIR? Vir Biotechnology has a consensus target price of $32.86, indicating a potential upside of 533.09%. Given Vir Biotechnology's stronger consensus rating and higher probable upside, analysts plainly believe Vir Biotechnology is more favorable than Tiziana Life Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tiziana Life Sciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Vir Biotechnology 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.86 Is TLSA or VIR more profitable? Tiziana Life Sciences has a net margin of 0.00% compared to Vir Biotechnology's net margin of -2,769.04%. Tiziana Life Sciences' return on equity of 0.00% beat Vir Biotechnology's return on equity.Company Net Margins Return on Equity Return on Assets Tiziana Life SciencesN/A N/A N/A Vir Biotechnology -2,769.04%-47.46%-39.33% Do institutionals & insiders believe in TLSA or VIR? 65.3% of Vir Biotechnology shares are held by institutional investors. 39.8% of Tiziana Life Sciences shares are held by insiders. Comparatively, 16.0% of Vir Biotechnology shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has more risk and volatility, TLSA or VIR? Tiziana Life Sciences has a beta of -0.09, indicating that its share price is 109% less volatile than the S&P 500. Comparatively, Vir Biotechnology has a beta of 1.24, indicating that its share price is 24% more volatile than the S&P 500. Which has better valuation and earnings, TLSA or VIR? Tiziana Life Sciences has higher earnings, but lower revenue than Vir Biotechnology. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTiziana Life SciencesN/AN/A-$11.86MN/AN/AVir Biotechnology$74.21M9.67-$521.96M-$4.22-1.23 SummaryVir Biotechnology beats Tiziana Life Sciences on 7 of the 12 factors compared between the two stocks. Get Tiziana Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for TLSA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TLSA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TLSA vs. The Competition Export to ExcelMetricTiziana Life SciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$184.62M$2.85B$5.42B$8.73BDividend YieldN/A2.69%5.37%4.21%P/E RatioN/A20.8425.0119.33Price / SalesN/A300.77404.46112.11Price / CashN/A43.0735.9456.46Price / Book43.757.337.985.50Net Income-$11.86M-$55.19M$3.14B$248.18M7 Day Performance9.37%1.09%0.89%0.76%1 Month Performance10.76%8.30%5.18%4.44%1 Year Performance80.41%-0.72%37.53%16.92% Tiziana Life Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TLSATiziana Life Sciences0.7991 of 5 stars$1.75+10.8%N/A+66.7%$184.62MN/A0.008VIRVir Biotechnology2.5674 of 5 stars$5.24+0.4%$32.86+527.0%-42.5%$724.37M$14.30M-1.34580Positive NewsXERSXeris Biopharma4.096 of 5 stars$4.40+1.1%$6.25+42.0%+120.9%$688.09M$222.55M-9.78290ABUSArbutus Biopharma1.5291 of 5 stars$3.58+1.4%$5.50+53.6%+9.8%$685.67M$6.40M-8.3390News CoverageANABAnaptysBio1.418 of 5 stars$23.90+2.5%$42.38+77.3%-3.0%$685.14M$111.87M-3.93100Positive NewsDAWNDay One Biopharmaceuticals1.4905 of 5 stars$6.64-0.4%$30.57+360.4%-52.1%$673.04M$161.92M-6.4560GHRSGH Research1.3288 of 5 stars$12.72-0.3%$32.00+151.6%+5.8%$661.80MN/A-16.1010Analyst ForecastKALVKalVista Pharmaceuticals3.8747 of 5 stars$13.04+0.6%$24.83+90.4%-0.2%$644.32MN/A-3.58100High Trading VolumeXNCRXencor3.5746 of 5 stars$9.05-1.5%$28.00+209.4%-58.8%$644.10M$127.23M-2.83280EOLSEvolus3.7115 of 5 stars$9.96+0.3%$23.75+138.5%-8.5%$640.25M$275.46M-10.94170STOKStoke Therapeutics3.72 of 5 stars$11.70+1.5%$23.20+98.3%-19.7%$638.79M$190.91M-5.57100Positive News Related Companies and Tools Related Companies VIR Competitors XERS Competitors ABUS Competitors ANAB Competitors DAWN Competitors GHRS Competitors KALV Competitors XNCR Competitors EOLS Competitors STOK Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TLSA) was last updated on 6/25/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tiziana Life Sciences Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Tiziana Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
